427.70
-1.20
(-0.28%)
At close: April 11 at 4:59:57 PM GMT+2
Research Analysis
Earnings Estimate
| Currency in DKK | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 14 | 14 |
| Avg. Estimate | -1.47 | 57.26 | 35 | -3.93 |
| Low Estimate | -6.9 | -7.1 | -29.4 | -36.84 |
| High Estimate | 16.72 | 130.7 | 129.12 | 48.16 |
| Year Ago EPS | -3.71 | -4.67 | -16.24 | 35 |
Revenue Estimate
| Currency in DKK | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 14 | 14 |
| Avg. Estimate | 248.61M | 4.89B | 4.86B | 2.28B |
| Low Estimate | 2.2M | 2.2M | -- | -- |
| High Estimate | 1.38B | 10.08B | 10.98B | 7.49B |
| Year Ago Sales | 15.09M | 34.13M | 62.69M | 4.86B |
| Sales Growth (year/est) | 1,547.62% | 14,218.26% | 7,658.34% | -53.21% |
Earnings History
| Currency in DKK | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | -4.2 | -3.98 | -3.47 | -4.29 |
| EPS Actual | -3.71 | -4.67 | -3.77 | -4.12 |
| Difference | 0.49 | -0.69 | -0.3 | 0.17 |
| Surprise % | 11.74% | -17.26% | -8.57% | 3.87% |
EPS Trend
| Currency in DKK | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -1.47 | 57.26 | 35 | -3.93 |
| 7 Days Ago | -1.47 | 57.26 | 35 | -3.93 |
| 30 Days Ago | -5.54 | -6.15 | -4.33 | -11.77 |
| 60 Days Ago | -2.26 | -2.51 | 4.18 | 17.71 |
| 90 Days Ago | -2.26 | -2.51 | 4.17 | 17.7 |
EPS Revisions
| Currency in DKK | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 2 | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 6 | 4 |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | 1 | 1 | 1 | 6 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ZEAL.CO | 60.49% | 1,326.16% | 315.49% | -111.24% |
| S&P 500 | 6.40% | 6.07% | 9.36% | 14.28% |
Related Tickers
GUBRA.CO Gubra A/S
377.00
+1.07%
GMAB.CO Genmab A/S
1,225.00
+0.66%
BAVA.CO Bavarian Nordic A/S
145.85
+0.24%
ALK-B.CO ALK-Abelló A/S
140.60
+2.33%
GMAB Genmab A/S
18.81
+4.44%
ASND Ascendis Pharma A/S
150.99
+5.34%
BVNRY Bavarian Nordic A/S
7.48
+5.50%
MTSR Metsera, Inc.
14.00
+7.03%
GPCR Structure Therapeutics Inc.
15.90
+5.65%
MRUS Merus N.V.
41.97
+8.67%